MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ
2.600
-0.110
-4.06%
Opening 15:59 11/19 EST
OPEN
2.760
PREV CLOSE
2.710
HIGH
2.820
LOW
2.520
VOLUME
217.16K
TURNOVER
--
52 WEEK HIGH
5.46
52 WEEK LOW
2.320
MARKET CAP
90.39M
P/E (TTM)
-8.3844
1D
5D
1M
3M
1Y
5Y
1D
Anixa Biosciences granted patent for ovarian cancer vaccine
TipRanks · 8h ago
Anixa Biosciences Issued Canadian Patent Covering Its Ovarian Cancer Vaccine Technology
Benzinga · 8h ago
Anixa Biosciences to collaborate with Curia on upcoming Phase 2 trial
TipRanks · 1d ago
Anixa Biosciences Taps Curia To Provide Formulation Development Services For Anixa's Investigational Breast Cancer Vaccine In Preparation For Upcoming Phase 2 Clinical Trial
Benzinga · 1d ago
Anixa Biosciences and Curia will Develop Final Formulation for Breast Cancer Vaccine in Preparation for Phase 2 Clinical Trial
PR Newswire · 1d ago
Weekly Report: what happened at ANIX last week (1109-1113)?
Weekly Report · 3d ago
Weekly Report: what happened at ANIX last week (1102-1106)?
Weekly Report · 11/09 10:13
Anixa Biosciences Form4 Filing Shows CEO Amit Kumar Reports Open Market Purchase Of 5,000 Common Shares On Oct 30 At An Average Price Of $3.17/Share
Benzinga · 11/02 14:05
More
About ANIX
Anixa Biosciences, Inc. is a biotechnology company. The Company is developing therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics program consists of the development of liraltagene autoleucel (lira-cel), a chimeric endocrine receptor-T cell therapy, which is a novel form of chimeric antigen receptor-T cell (CAR-T) technology, initially focused on treating ovarian cancer, that is being developed of its subsidiary, Certainty Therapeutics, Inc. (Certainty). Its vaccine programs include the development of a vaccine against breast cancer, the development of a vaccine against ovarian cancer, and a vaccine discovery program utilizing the same mechanism of its breast and ovarian cancer vaccines to develop additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon and prostate. It is also developing a method to vaccinate women against breast cancer, focused on triple-negative breast cancer.

Webull offers Anixa Biosciences Inc stock information, including NASDAQ: ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIX stock methods without spending real money on the virtual paper trading platform.